BRPI0804929A2 - antiseptic ointment for microbial control of the internal surface of dental implants - Google Patents
antiseptic ointment for microbial control of the internal surface of dental implantsInfo
- Publication number
- BRPI0804929A2 BRPI0804929A2 BRPI0804929-7A BRPI0804929A BRPI0804929A2 BR PI0804929 A2 BRPI0804929 A2 BR PI0804929A2 BR PI0804929 A BRPI0804929 A BR PI0804929A BR PI0804929 A2 BRPI0804929 A2 BR PI0804929A2
- Authority
- BR
- Brazil
- Prior art keywords
- dental implants
- implants
- ointment
- control
- antiseptic
- Prior art date
Links
- 230000002421 anti-septic effect Effects 0.000 title abstract 4
- 239000004053 dental implant Substances 0.000 title abstract 4
- 230000000813 microbial effect Effects 0.000 title abstract 4
- 239000002674 ointment Substances 0.000 title abstract 4
- 239000007943 implant Substances 0.000 abstract 3
- 206010065687 Bone loss Diseases 0.000 abstract 2
- 238000011109 contamination Methods 0.000 abstract 2
- OKJPEAGHQZHRQV-UHFFFAOYSA-N iodoform Chemical compound IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 abstract 2
- 230000005923 long-lasting effect Effects 0.000 abstract 2
- AJBZENLMTKDAEK-UHFFFAOYSA-N 3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-4,9-diol Chemical compound CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3O)(C)C2CCC1C1C3(C)CCC1C(=C)C AJBZENLMTKDAEK-UHFFFAOYSA-N 0.000 abstract 1
- 241000132025 Calendula Species 0.000 abstract 1
- 235000003880 Calendula Nutrition 0.000 abstract 1
- 239000004166 Lanolin Substances 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 235000013871 bee wax Nutrition 0.000 abstract 1
- 239000012166 beeswax Substances 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 235000019388 lanolin Nutrition 0.000 abstract 1
- 229940039717 lanolin Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
POMADA ANTI-SéPTICA PARA O CONTROLE MICROBIANO DA SUPERFìCIE INTERNA DOS IMPLANTES DENTAIS. Patente de Invenção que diz respeito a uma pomada a ser utilizada no interior dos implantes dentais evitando a sua contaminação e consequente crescimento microbiano. Existem evidências científicas da contaminação e crescimento bacteriano no interior dos implantes dentais, junto às conexões e roscas dos dispositivos que nele são acoplados, que podem levar a perda óssea em torno destes implantes. A utilização de uma pomada anti-séptica com efeito de longa duração, aplicada neste ambiente implante-conexão pode controlar o crescimento microbiano e evitar as perdas ósseas perlimplantares e do próprio implante. A formulação é baseada em um anti-séptico de longa duração (iodofórmio) que levado pelo veículo composto de Calêndula, Lanolina Anidra, Cera de Abelha e Nipazol, pode manter o efeito terapêutico por longo tempo, sendo capaz de controlar o ambiente interno dos implantes, sem causar dano aos tecidos vivos.Antiseptic ointment for the microbial control of the internal surface of dental implants. Patent of Invention which relates to an ointment to be used inside dental implants to prevent contamination and consequent microbial growth. There is scientific evidence of bacterial contamination and growth inside dental implants, along with the connections and threads of the devices attached to them, which can lead to bone loss around these implants. The use of a long-lasting antiseptic ointment applied in this implant-connection environment can control microbial growth and prevent perlimplant and implant bone loss. The formulation is based on a long-lasting antiseptic (iodoform) that carried by the vehicle composed of Calendula, Lanolin Anhydrous, Beeswax and Nipazole, can maintain the therapeutic effect for a long time, being able to control the internal environment of the implants. without causing damage to living tissues.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BRPI0804929-7A BRPI0804929A2 (en) | 2008-04-08 | 2008-04-08 | antiseptic ointment for microbial control of the internal surface of dental implants |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BRPI0804929-7A BRPI0804929A2 (en) | 2008-04-08 | 2008-04-08 | antiseptic ointment for microbial control of the internal surface of dental implants |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0804929A2 true BRPI0804929A2 (en) | 2009-09-01 |
Family
ID=41010142
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0804929-7A BRPI0804929A2 (en) | 2008-04-08 | 2008-04-08 | antiseptic ointment for microbial control of the internal surface of dental implants |
Country Status (1)
| Country | Link |
|---|---|
| BR (1) | BRPI0804929A2 (en) |
-
2008
- 2008-04-08 BR BRPI0804929-7A patent/BRPI0804929A2/en not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0610901A2 (en) | METHOD OF USING AN AXOXY-REDUCTIVE POTENTIAL SOLUTION IN DENTAL APPLICATIONS | |
| Ferraris et al. | Antibacterial titanium surfaces for medical implants | |
| Van der Borden et al. | Prevention of pin tract infection in external stainless steel fixator frames using electric current in a goat model | |
| Williams et al. | Experimental model of biofilm implant‐related osteomyelitis to test combination biomaterials using biofilms as initial inocula | |
| CL2010001260A1 (en) | Pharmaceutical composition comprising a salt of strontium and vitamin D and a cyclodextrin, where the mass ratio between the amount of vitamin D and the amount of cyclodextrin is between 1/40 and 1/800, useful for treating or preventing osteoporosis. | |
| BRPI0719821B8 (en) | storage stable composition suitable for administration to patients | |
| BRPI1012219C1 (en) | product, substrate, pharmaceutical composition, uses of a product, and an antimicrobial peptide, methods to prevent biofilm formation in an environment, to treat a microbial infection by prophylaxis or therapy, and to treat or prevent biofilm formation in an environment, and, use of a cysteamine | |
| BR112015028385A2 (en) | A composition comprising lactic acid bacteria for use in the preventive and / or curative treatment of bacterial vaginosis. | |
| MX2016010899A (en) | An a22k, desb27, b29r, des b30, at epsilon position of lysine 22 acylated human insulin analogue. | |
| BR112014018421A8 (en) | ANTIMICROBIAL COMPOSITIONS COMPRISING DGLA, 15-OHEPA AND/OR 15-HETRE AND METHODS OF USE THEREOF | |
| MX2012010048A (en) | COMPOSITION FOR FREE MOLIBDATE STERILIZATION CONTAINING PERACETIC ACID. | |
| EA201591152A1 (en) | AMORPHOUS CARBONATE CARBONATE FOR ACCELERATED GROWTH OF BONE TISSUE | |
| BR112012015433B8 (en) | substantially anhydrous pharmaceutical composition for cutaneous application | |
| CL2008003545A1 (en) | Compounds derived from [(imidazol-1-yl) -1-hydroxy-1-phosphono-ethyl] -phosphonic acid; Preparation method; pharmaceutical composition; and use for the treatment of excessive or inappropriate bone resorption or disease caused by excessive preylation of target proteins. | |
| EP4216760A4 (en) | Device for removal of bacteria and biofilms from surfaces of implantable medical devices as well as from the surgical site | |
| Srivastava et al. | The role of biofilms in medical devices and implants | |
| BR112015032284A2 (en) | medical device comprising collagen-vi | |
| EA201790382A1 (en) | METHODS OF TREATMENT OF PERIIMPLANTITA | |
| BR112017027909A2 (en) | composition and use of a composition | |
| MX2018011539A (en) | Treatment of skin conditions and diseases associated with microbial biofilms. | |
| BRPI0804929A2 (en) | antiseptic ointment for microbial control of the internal surface of dental implants | |
| Radhamony et al. | Analysis of incidence of postoperative wound infection in closed fractures treated by surgical fixation–A prospective study | |
| CO2021004612A2 (en) | 4-pyrazin-2-ylmethyl-morpholine derivatives and their use as a medicine | |
| Romanò et al. | ICS classification system of infected osteosynthesis: Long-term results | |
| CR20220449A (en) | Pharmaceutical compositions of lipoic acid choline ester salts and methods of treatment using same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B03B | Publication of an application: publication anticipated [chapter 3.2 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 11, 13, 24 E 25 DA LPI |
|
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |